| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. (ABEO) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ABEO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.43M | $8.17M | - | |
| CFO | 587.2K | $3.35M | - | |
| VP | 464.7K | $2.65M | - | |
| Dir | 145.4K | $830.4K | - | |
| Dir | 139.1K | $794.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | Sco Capital Partners LLC83 | - | Sell | 240,000 | $3.01 | $722,832.00 | -2.1% | -60.2% | -92.6% | |
| Jan 19, 2021 | Sco Capital Partners LLC83 | - | Sell | 320,000 | $2.06 | $658,516.23 | -0.9% | - | - | |
| Jan 4, 2021 | Wider Todd83 | Director | Sell | 33,876 | $1.54 | $52,064.02 | -10.9% | - | - | |
| Jan 4, 2021 | Mann Paul Elliot | Director | Sell | 30,488 | $1.54 | $46,890.54 | -18.7% | - | - | |
| Dec 18, 2020 | Mann Paul Elliot | - | Sell | 17,079 | $1.59 | $27,099.25 | -2.2% | - | - | |
| Dec 2, 2020 | Mann Paul Elliot | - | Sell | 30,488 | $1.49 | $45,369.19 | -3.7% | - | - | |
| Dec 2, 2020 | Wider Todd83 | - | Sell | 33,876 | $1.49 | $50,546.38 | -3.6% | - | - | |
| Nov 23, 2020 | Wider Todd83 | - | Sell | 17,969 | $1.33 | $23,981.43 | -1.8% | - | - | |
| Nov 2, 2020 | Mann Paul Elliot | Director | Sell | 30,488 | $1.04 | $31,588.62 | -3.6% | - | - | |
| Nov 2, 2020 | Wider Todd83 | - | Sell | 33,876 | $1.04 | $35,105.70 | -3.4% | - | - |